Current Administrative Positions
- Associate Professor of Clinical OtolaryngologyÃ¢â‚¬â€Head and Neck Surgery
- Chief, Division of Pediatric OtolaryngologyÃ¢â‚¬â€Head and Neck Surgery
- John and De Graaf Woodman Endowed Chair
Eli Grunstein, M.D. is the John and De Graaf Woodman Associate Professor of Clinical Otolaryngology—Head & Neck Surgery at the Columbia University College of Physicians and Surgeons and Assistant Attending physician at NewYork-Presbyterian/ Morgan Stanley Children's Hospital. He specializes in general Pediatric Otolaryngology, with specific clinical interest in pediatric throat and airway diseases, hyper nasality, and pediatric sinonasal diseases.
Dr. Grunstein received his medical degree from the Albert Einstein College of Medicine. He completed his Otolaryngology—Head and Neck Surgery residency training at Columbia University Medical Center and The Weill Cornell Medical Center in New York, then a fellowship in Pediatric Otolaryngology at Children's Hospital and Regional Medical Center in Seattle, Washington.
Dr. Grunstein is a member of the American Academy of Otolaryngology/Head and Neck Surgery and is Board Certified in Otolaryngology. He is author or co-author of a number of journal articles and textbook chapters. His current research project is focused on novel ways to prevent intubation related laryngeal injury.
Education and Training
- Albert Einstein College of Medicine of Yeshiva University
- Internship: NewYork-Presbyterian Hospital/Columbia University Medical Center
- Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center
- Residency: 2005 NewYork-Presbyterian/Columbia University Medical C
- Fellowship: Children's Hospital and Regional Medical Center in Seattle, WA
- Fellowship: 2006 Children's Hospital & Regional Medical Center
APROSPECTIVE, SINGLE-ARM, MULTICENTER STUDY TO EVALUATE EFFECTIVENESS AND SAFETY OF TYMPANOSTOMY TUBE PLACEMENT USING THE TULA IONTOPHORESIS AND TUBE DELIVERY SYSTEMS FOR CHILDREN IN AN OFFICE SETTING (P&S Industry Clinical Trial)
Feb 28 2018 - Feb 28 2023
RANDOMIZED CONTROLLED TRIAL OF VALGANCICLOVIR FOR ASYMPTOMATIC CYTOMEGALOVIRUS INFECTED HEARING IMPAIRED INFANTS (VALEAR TRIAL) (Federal Gov)
Jul 6 2017 - Jun 30 2022